Literature DB >> 8116188

Immunogens of rotaviruses.

P S Paul1, Y S Lyoo.   

Abstract

Rotaviruses cause gastroenteritis in neonates of many animal species including cattle, swine, horses, dogs, cats, chickens and turkeys. Rotavirions are nonenveloped, are about 75 nm in diameter, have a double capsid, and contain 11 double-stranded RNA segments as their genome. Several antigenically distinct groups of rotaviruses have been identified and have been alphabetically designated as A through G. Group A rotaviruses were the first group of rotaviruses isolated and are the most commonly detected rotaviruses in diarrheic animals. Group A rotaviruses have two surface proteins, VP4 and VP7, both of which are important in serotype determination and in inducing neutralizing antibodies and protective immunity. Multiple serotypes of group A rotavirus based on glycoprotein VP7 (designated as G types) and based on VP4 (P types) have been identified. The immune response to rotaviruses is essentially serotype specific, however, cross-reactive or heterotypic epitopes have also been identified. Currently acceptable methods for immunogen quantitation include the induction of neutralizing antibody in host or laboratory animals. The in vivo efficacy of vaccines against rotavirus-associated gastroenteritis remains the standard method against which in vitro methods must be compared. Several animal models have been developed which could potentially be used in evaluating the efficacy of candidate vaccines. Monoclonal antibodies to rotavirus immunogens are also currently available and serve as valuable reagents for in vitro quantitation of rotaviral immunogens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8116188     DOI: 10.1016/0378-1135(93)90031-2

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  8 in total

1.  Sequence and phylogenetic analysis of the VP7 gene of a bovine rotavirus with G6 subtype.

Authors:  S Mummidi; P S Paul; R E Holland
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

2.  Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed by Lactococcus lactis induces specific antibody production.

Authors:  Yi-jing Li; Guang-peng Ma; Gui-wei Li; Xin-yuan Qiao; Jun-wei Ge; Li-jie Tang; Min Liu; Li-wei Liu
Journal:  J Biomed Biotechnol       Date:  2010-06-06

3.  Relationship between group A porcine rotavirus and management practices in swine herds in Ontario.

Authors:  Cate Dewey; Susy Carman; Tim Pasma; Gaylan Josephson; Beverly McEwen
Journal:  Can Vet J       Date:  2003-08       Impact factor: 1.008

4.  Rotavirus C: prevalence in suckling piglets and development of virus-like particles to assess the influence of maternal immunity on the disease development.

Authors:  Juliet Chepngeno; Annika Diaz; Francine C Paim; Linda J Saif; Anastasia N Vlasova
Journal:  Vet Res       Date:  2019-10-22       Impact factor: 3.683

5.  Frequency of group A rotavirus in diarrhoeic calves in Brazilian cattle herds, 1998-2002.

Authors:  A A Alfieri; M E Parazzi; E Takiuchi; K C Médici; A F Alfieri
Journal:  Trop Anim Health Prod       Date:  2006 Oct-Nov       Impact factor: 1.559

6.  Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice.

Authors:  Xinyuan Qiao; Guiwei Li; Xiangqing Wang; Xiaojing Li; Min Liu; Yijing Li
Journal:  BMC Microbiol       Date:  2009-12-04       Impact factor: 3.605

Review 7.  Rotavirus diarrhea in bovines and other domestic animals.

Authors:  K Dhama; R S Chauhan; M Mahendran; S V S Malik
Journal:  Vet Res Commun       Date:  2008-07-12       Impact factor: 2.459

8.  Surface Display of Antigen Protein VP8* of Porcine Rotavirus on Bacillus Subtilis Spores Using CotB as a Fusion Partner.

Authors:  Wanqiang Li; Jie Feng; Jiajun Li; Jianzhen Li; Zhenhua Wang; Abdul Khalique; Miao Yang; Xueqin Ni; Dong Zeng; Dongmei Zhang; Bo Jing; Qihui Luo; Kangcheng Pan
Journal:  Molecules       Date:  2019-10-22       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.